158 related articles for article (PubMed ID: 28267564)
41. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry.
El-Alfy M; Luu-The V; Huang XF; Berger L; Labrie F; Pelletier G
Endocrinology; 1999 Mar; 140(3):1481-91. PubMed ID: 10067877
[TBL] [Abstract][Full Text] [Related]
42. Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.
Bydal P; Luu-The V; Labrie F; Poirier D
Eur J Med Chem; 2009 Feb; 44(2):632-44. PubMed ID: 18472187
[TBL] [Abstract][Full Text] [Related]
43. In situ androgen producing enzymes in human prostate cancer.
Nakamura Y; Suzuki T; Nakabayashi M; Endoh M; Sakamoto K; Mikami Y; Moriya T; Ito A; Takahashi S; Yamada S; Arai Y; Sasano H
Endocr Relat Cancer; 2005 Mar; 12(1):101-7. PubMed ID: 15788642
[TBL] [Abstract][Full Text] [Related]
44. Chemical synthesis of fluorinated and iodinated 17β-HSD3 inhibitors and evaluation for imaging prostate cancer tumors and tissue biodistribution.
Poirier D; Maltais R; Rousseau JA; Roy J; Phoenix S; Cortés-Benítez F; Lecomte R
Bioorg Chem; 2022 Dec; 129():106145. PubMed ID: 36174444
[TBL] [Abstract][Full Text] [Related]
45. Reprint of "In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3".
Roy J; Fournier MA; Maltais R; Kenmogne LC; Poirier D
J Steroid Biochem Mol Biol; 2015 Sep; 153():170-8. PubMed ID: 26291835
[TBL] [Abstract][Full Text] [Related]
46. 3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer.
Evaul K; Li R; Papari-Zareei M; Auchus RJ; Sharifi N
Endocrinology; 2010 Aug; 151(8):3514-20. PubMed ID: 20534728
[TBL] [Abstract][Full Text] [Related]
47. Identification of chemically diverse, novel inhibitors of 17β-hydroxysteroid dehydrogenase type 3 and 5 by pharmacophore-based virtual screening.
Schuster D; Kowalik D; Kirchmair J; Laggner C; Markt P; Aebischer-Gumy C; Ströhle F; Möller G; Wolber G; Wilckens T; Langer T; Odermatt A; Adamski J
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):148-61. PubMed ID: 21300150
[TBL] [Abstract][Full Text] [Related]
48. Castration inhibits biliary proliferation induced by bile duct obstruction: novel role for the autocrine trophic effect of testosterone.
Yang F; Priester S; Onori P; Venter J; Renzi A; Franchitto A; Munshi MK; Wise C; Dostal DE; Marzioni M; Saccomanno S; Ueno Y; Gaudio E; Glaser S
Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G981-91. PubMed ID: 21903763
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of 17β-hydroxysteroid dehydrogenase activity using androgen receptor-mediated transactivation.
Yazawa T; Imamichi Y; Uwada J; Sekiguchi T; Mikami D; Kitano T; Ida T; Sato T; Nemoto T; Nagata S; Islam Khan MR; Takahashi S; Ushikubi F; Suzuki N; Umezawa A; Taniguchi T
J Steroid Biochem Mol Biol; 2020 Feb; 196():105493. PubMed ID: 31614207
[TBL] [Abstract][Full Text] [Related]
50. Crystal structures of the multispecific 17beta-hydroxysteroid dehydrogenase type 5: critical androgen regulation in human peripheral tissues.
Qiu W; Zhou M; Labrie F; Lin SX
Mol Endocrinol; 2004 Jul; 18(7):1798-807. PubMed ID: 15087468
[TBL] [Abstract][Full Text] [Related]
51. Pitfalls in hormonal diagnosis of 17-beta hydroxysteroid dehydrogenase III deficiency.
Khattab A; Yuen T; Yau M; Domenice S; Frade Costa EM; Diya K; Muhuri D; Pina CE; Nishi MY; Yang AC; de Mendonça BB; New MI
J Pediatr Endocrinol Metab; 2015 May; 28(5-6):623-8. PubMed ID: 25536660
[TBL] [Abstract][Full Text] [Related]
52. Discovery of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol: a novel, potent and selective type 5 17β-hydroxysteroid dehydrogenase inhibitor.
Watanabe K; Kakefuda A; Yasuda M; Enjo K; Kikuchi A; Furutani T; Naritomi Y; Otsuka Y; Okada M; Ohta M
Bioorg Med Chem; 2013 Sep; 21(17):5261-70. PubMed ID: 23845281
[TBL] [Abstract][Full Text] [Related]
53. Altered expression of 3β-HSD, CYP17 and 17β-HSD in the foetal porcine gonads in response to anti-androgen flutamide exposure.
Knapczyk-Stwora K; Grzesiak M; Slomczynska M
Reprod Domest Anim; 2014 Oct; 49(5):725-33. PubMed ID: 25130044
[TBL] [Abstract][Full Text] [Related]
54. Identification of oxazolidinediones and thiazolidinediones as potent 17β-hydroxysteroid dehydrogenase type 3 inhibitors.
Harada K; Kubo H; Tanaka A; Nishioka K
Bioorg Med Chem Lett; 2012 Jan; 22(1):504-7. PubMed ID: 22137341
[TBL] [Abstract][Full Text] [Related]
55. Steroid 17β-hydroxysteroid dehydrogenase deficiency in man: an inherited form of male pseudohermaphroditism.
Rösler A
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):989-1002. PubMed ID: 22217844
[TBL] [Abstract][Full Text] [Related]
56. Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women.
Luu-The V; Tremblay P; Labrie F
Mol Endocrinol; 2006 Feb; 20(2):437-43. PubMed ID: 16166196
[TBL] [Abstract][Full Text] [Related]
57. Preclinical Pharmacokinetics, Tissue Distribution and Primary Safety Evaluation of a Novel Curcumin Analogue H10 Suspension, a Potential 17β Hydroxysteroid Dehydrogenase Type 3 Inhibitor.
Xiao L; Bei Y; Li J; Chen M; Zhang Y; Xiang Q
Chem Pharm Bull (Tokyo); 2021 Jan; 69(1):52-58. PubMed ID: 33087639
[TBL] [Abstract][Full Text] [Related]
58. Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis.
Day JM; Tutill HJ; Purohit A; Reed MJ
Endocr Relat Cancer; 2008 Sep; 15(3):665-92. PubMed ID: 18541621
[TBL] [Abstract][Full Text] [Related]
59. Biological activity of pyrazole and imidazole-dehydroepiandrosterone derivatives on the activity of 17β-hydroxysteroid dehydrogenase.
Cabeza M; Posada A; Sánchez-Márquez A; Heuze Y; Moreno I; Soriano J; Garrido M; Cortés F; Bratoeff E
J Enzyme Inhib Med Chem; 2016; 31(1):53-62. PubMed ID: 25690043
[TBL] [Abstract][Full Text] [Related]
60. A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females.
Rösler A; Silverstein S; Abeliovich D
J Clin Endocrinol Metab; 1996 May; 81(5):1827-31. PubMed ID: 8626842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
